Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124768722 | 12476872 | 2 | F | 2012 | 20160921 | 20160617 | 20160928 | EXP | US-DSJP-DSU-2016-120661 | DAIICHI | 0.00 | Y | 0.00000 | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124768722 | 12476872 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | ||||||
| 124768722 | 12476872 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | U | 21286 | 20 | MG | TABLET | QD | |||||
| 124768722 | 12476872 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40-12.5 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 124768722 | 12476872 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 124768722 | 12476872 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 100 UNITS/ML, UNK | 0 | QD | |||||||||
| 124768722 | 12476872 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 80 MG, UNK | 0 | 80 | MG | |||||||||
| 124768722 | 12476872 | 7 | C | VITAMIN D3 APOLOGO | 2 | Oral | 2000 INTL UNITS, QD | 0 | 1 | DF | TABLET | QD | |||||||
| 124768722 | 12476872 | 8 | C | NEPHRO-VITE /01801401/ | 2 | 0 | |||||||||||||
| 124768722 | 12476872 | 9 | C | INSULIN /00646001/ | INSULIN NOS | 1 | Subcutaneous | 10 UNITS/ML, QD | 0 | QD | |||||||||
| 124768722 | 12476872 | 10 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
| 124768722 | 12476872 | 11 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | 0 | ||||||||||||
| 124768722 | 12476872 | 12 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 100 MG, BID | 0 | 100 | MG | BID | |||||||
| 124768722 | 12476872 | 13 | C | LACTULOSE. | LACTULOSE | 1 | 30 ML, QD | 0 | 30 | ML | QD | ||||||||
| 124768722 | 12476872 | 14 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, BID | 0 | 325 | MG | TABLET | BID | |||||||
| 124768722 | 12476872 | 15 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | Oral | 667 MG, UNK | 0 | 667 | MG | CAPSULE | |||||||
| 124768722 | 12476872 | 16 | C | AMOX TR-K | 2 | 0 | |||||||||||||
| 124768722 | 12476872 | 17 | C | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 18 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 19 | C | NYSTATIN. | NYSTATIN | 1 | 0 | ||||||||||||
| 124768722 | 12476872 | 20 | C | ACETAMINOPHEN W/OXYCODONE | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 5/325 MG, PRN | 0 | 1 | DF | TABLET | |||||||
| 124768722 | 12476872 | 21 | C | ASTEPRO | AZELASTINE HYDROCHLORIDE | 1 | 205.5 ?G, BID | 0 | 205.5 | UG | INHALER | BID | |||||||
| 124768722 | 12476872 | 22 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 23 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | UNK, BID | 0 | BID | ||||||||||
| 124768722 | 12476872 | 24 | C | TRADJENTA | LINAGLIPTIN | 1 | 5 MG, QD | 0 | 5 | MG | TABLET | QD | |||||||
| 124768722 | 12476872 | 25 | C | LATANOPROST. | LATANOPROST | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 26 | C | PROLENSA | BROMFENAC SODIUM | 1 | 0 | ||||||||||||
| 124768722 | 12476872 | 27 | C | PREDNISOLONE ACETATE. | PREDNISOLONE ACETATE | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 28 | C | OFLOXACIN. | OFLOXACIN | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 29 | C | MOMETASONE FUROATE. | MOMETASONE FUROATE | 1 | UNK | 0 | |||||||||||
| 124768722 | 12476872 | 30 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 124768722 | 12476872 | 31 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, TID | 0 | 40 | MG | TID | |||||||
| 124768722 | 12476872 | 32 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, TID | 0 | 25 | MG | TID | |||||||
| 124768722 | 12476872 | 33 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | QD | |||||||
| 124768722 | 12476872 | 34 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124768722 | 12476872 | 1 | Hypertension |
| 124768722 | 12476872 | 3 | Hypertension |
| 124768722 | 12476872 | 4 | Product used for unknown indication |
| 124768722 | 12476872 | 5 | Diabetes mellitus |
| 124768722 | 12476872 | 6 | Product used for unknown indication |
| 124768722 | 12476872 | 7 | Vitamin D deficiency |
| 124768722 | 12476872 | 8 | Product used for unknown indication |
| 124768722 | 12476872 | 9 | Product used for unknown indication |
| 124768722 | 12476872 | 10 | Product used for unknown indication |
| 124768722 | 12476872 | 11 | Product used for unknown indication |
| 124768722 | 12476872 | 12 | Product used for unknown indication |
| 124768722 | 12476872 | 13 | Product used for unknown indication |
| 124768722 | 12476872 | 14 | Product used for unknown indication |
| 124768722 | 12476872 | 15 | Product used for unknown indication |
| 124768722 | 12476872 | 16 | Product used for unknown indication |
| 124768722 | 12476872 | 17 | Product used for unknown indication |
| 124768722 | 12476872 | 18 | Product used for unknown indication |
| 124768722 | 12476872 | 19 | Product used for unknown indication |
| 124768722 | 12476872 | 20 | Product used for unknown indication |
| 124768722 | 12476872 | 21 | Product used for unknown indication |
| 124768722 | 12476872 | 22 | Product used for unknown indication |
| 124768722 | 12476872 | 23 | Product used for unknown indication |
| 124768722 | 12476872 | 24 | Product used for unknown indication |
| 124768722 | 12476872 | 25 | Product used for unknown indication |
| 124768722 | 12476872 | 26 | Product used for unknown indication |
| 124768722 | 12476872 | 27 | Product used for unknown indication |
| 124768722 | 12476872 | 28 | Product used for unknown indication |
| 124768722 | 12476872 | 29 | Product used for unknown indication |
| 124768722 | 12476872 | 30 | Product used for unknown indication |
| 124768722 | 12476872 | 31 | Gastrooesophageal reflux disease |
| 124768722 | 12476872 | 32 | Product used for unknown indication |
| 124768722 | 12476872 | 33 | Product used for unknown indication |
| 124768722 | 12476872 | 34 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124768722 | 12476872 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124768722 | 12476872 | Dizziness | |
| 124768722 | 12476872 | Gastrointestinal haemorrhage | |
| 124768722 | 12476872 | Gastrooesophageal reflux disease | |
| 124768722 | 12476872 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124768722 | 12476872 | 1 | 20051030 | 20150809 | 0 | |
| 124768722 | 12476872 | 3 | 20051030 | 20150809 | 0 |